Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?

MLA

Boriani, Giuseppe, et al. “Detection of Subclinical Atrial Fibrillation with Cardiac Implanted Electronic Devices: What Decision Making on Anticoagulation after the NOAH and ARTESiA Trials?” European Journal of Internal Medicine, vol. 123, May 2024, pp. 37–41. EBSCOhost, https://doi.org/10.1016/j.ejim.2024.01.002.

APA

Boriani, G., Gerra, L., Mei, D. A., Bonini, N., Vitolo, M., Proietti, M., & Imberti, J. F. (2024). Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? European Journal of Internal Medicine, 123, 37–41. https://doi.org/10.1016/j.ejim.2024.01.002

Chicago

Boriani, Giuseppe, Luigi Gerra, Davide A Mei, Niccolo’ Bonini, Marco Vitolo, Marco Proietti, and Jacopo F Imberti. 2024. “Detection of Subclinical Atrial Fibrillation with Cardiac Implanted Electronic Devices: What Decision Making on Anticoagulation after the NOAH and ARTESiA Trials?” European Journal of Internal Medicine 123 (May): 37–41. doi:10.1016/j.ejim.2024.01.002.